SI-BONE, Inc. SIBN | NASDAQ

$23.73 -$0.02 | -0.08%
TREND SIGNAL:Signal available — unlock to view |2026-11-03

Company Overview:

Market Cap: $1.07B
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $11.48 - $25.92

8.1 Year SIBN Performance Metrics:

Total Return (with DRIP): 18.3% (2.10% CAGR)
Total Return (no DRIP): 18.3% (2.10% CAGR)
Share Price: 18.3% (2.10% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $11,830
Total Return $ (with DRIP): $1,830
SIBN Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
SIBN Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
Build Custom Charts
SIBN - Chart 1
SIBN - Chart 2
SIBN - Chart 3

SIBN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

Revenue
SIBN Revenue CAGR:1Y: 14.49%2Y: 17.51%5Y: 20.11%10Y: 18.36%
Earnings Per Share (EPS)
SIBN EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Net Income
SIBN Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EBITDA
SIBN EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Free Cash Flow
SIBN Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Free Cash Flow / Share
SIBN Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Operating Income
SIBN Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Gross Profit
SIBN Gross Profit CAGR:1Y: 13.70%2Y: 17.66%5Y: 17.40%10Y: 17.84%
Shares Outstanding
SIBN Shares Outstanding CAGR:1Y: 3.96%2Y: 3.74%5Y: 6.13%10Y: 31.42%
Share Buybacks
SIBN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Stock-Based Comp
SIBN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Expenses
SIBN Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Revenue vs Net Income
EPS vs FCF / Share
EPS vs PE Ratio
FCF vs FCF / Share
FCF vs Stock Based Comp
Cash & Debt
Revenue by Region
SIBN Revenue CAGR:1Y: 14.49%2Y: 17.51%5Y: 20.11%10Y: 18.36%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

REVENUE: Actual + Estimates
SIBN Actual Revenue CAGR:1Y: 14.49%2Y: 17.51%5Y: 20.11%10Y: 18.36%
EPS: Actual + Estimates
SIBN Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
NET INCOME: Actual + Estimates
SIBN Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
EBITDA: Actual + Estimates
SIBN Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

Net Profit Margin
SIBN Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Gross Profit Margin
SIBN Gross Profit Margin CAGR:1Y: -0.69%2Y: 0.13%5Y: -2.26%10Y: -0.44%
Price to Earnings
SIBN Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Price To Sales Ratio
SIBN Price To Sales Ratio CAGR:1Y: 15.98%2Y: 2.38%5Y: -13.91%10Y: 10.31%
Return on Capital Employed
SIBN Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Return on Invested Capital
SIBN Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

Projected Future Returns & Dividends for SIBN

Based on past 8.1-year performance, here are SIBN growth metrics:

Share price CAGR of +2.1%
Dividend CAGR of +0%

Using SIBN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

SIBN (DRIP)SIBN - No DRIP
Current Price$23.73$23.73
Start Shares421.41421.41
Start Value$10,000$10,000
  
After 10 years:
Final Share Count421.41421.41
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$23.73$23.73
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - SIBN

NOTE: Above numbers are our estimate based on SIBN's Dividend and Price CAGR over past 8.1 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Company Info

SI-BONE, Inc. (SIBN) had its IPO on 2018-10-17, and is traded on NASDAQ stock exchange.

SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.

SIBN website: https://si-bone.com


Loading signals…

DCF Model — SIBN

Value from:
Pay up to today
—
vs current price $23.73
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →